laitimes

2024-2028 China automated pharmacy industry in-depth research and market investment risk consulting report

author:Xinsijie.com

Automated pharmacies have a broad space for development and the market scale is expanding

  Automated pharmacy refers to the use of artificial intelligence and machine transmission means to improve the efficiency of drug storage and transportation in retail terminals, reduce the error rate, save valuable business area, so as to optimize the business process of retail enterprises, has been widely used in developed countries around the world.

2024-2028 China automated pharmacy industry in-depth research and market investment risk consulting report

  In recent years, local governments have issued a number of policies to encourage and support automatic drug sales, providing a good development environment for automated pharmacies. In November 2022, the Shandong Provincial Medical Security Bureau and other departments jointly issued the "Several Measures on Innovative Supervision to Promote the High-quality Development of the Drug Circulation Industry", proposing that all localities should actively explore, study and formulate standards for the establishment of Class B non-prescription drug sales counters and automatic drug vending machines, and strengthen supervision and services.

  With the continuous improvement of national living standards, the continuous enhancement of health awareness, the acceleration of the process of social aging, the growing number of elderly population, and the increasing medical demand, the per capita health care expenditure of mainland residents has been increasing in recent years, and automated pharmacies have a broad consumer market. According to data released by the National Bureau of Statistics, in 2023, the per capita consumption expenditure of residents in health care across the country will be 2,460 yuan, an increase of 16% over the previous year, accounting for 9.2% of the per capita consumption expenditure.

2024-2028 China automated pharmacy industry in-depth research and market investment risk consulting report

  The upstream of the automated pharmacy industry chain is the supply of mechanical parts, electronic components and other parts; The downstream is mainly used in pharmacies, medical institutions, etc. In the context of the gradual acceleration of the transformation and upgrading of the medical industry, the level of medical and health services in mainland China has been continuously improved, high-quality medical resources have gradually sunk, and the number of hospitals has been increasing, providing a broad space for the development of automated pharmacies. According to data released by the National Bureau of Statistics, by the end of 2023, the total number of medical and health institutions in mainland China reached 1.071 million.

  According to the "2024-2028 China Automated Pharmacy Industry In-depth Research and Market Investment Risk Consulting Report" released by the Xinsijie Industry Research Center, with the continuous increase of national support for the pharmaceutical industry and the increasing demand for downstream drugs, the R&D and production process of drugs in mainland China has been accelerating in recent years, and the sales scale of the drug circulation market has maintained a growth trend. In the context of the continuous advancement of medical reform and the continuous improvement of the modern drug circulation system, the market has continuously improved the requirements for the speed and quality of drug circulation, and the market scale of automated pharmacies has been expanding as one of the effective ways to improve the modernization level of drug circulation. In 2019, the market size of automated pharmacies in mainland China was about 12 billion yuan, and in 2023, the market size will be about 21 billion yuan, with a compound annual growth rate of about 15% from 2019 to 2023.

2024-2028 China automated pharmacy industry in-depth research and market investment risk consulting report

  Industry analysts said that compared with developed countries in Europe and the United States, the mainland automated pharmacy industry started late, and its penetration rate in pharmaceutical, pharmacy and other scenarios is at a low level, and the industry has great development potential. In the context of the continuous improvement of the informatization and intelligence level of the medical industry, the number of automated pharmacy-related enterprises will continue to increase, the penetration rate in hospitals and pharmacies will continue to increase, and the market scale will maintain a growth trend.

2024-2028 China automated pharmacy industry in-depth research and market investment risk consulting report

Excerpt from the report: New Thinking World

.....

Second, the business data

3. Enterprise product analysis

Section 6 E Enterprises

First, the company profile

Second, the business data

3. Enterprise product analysis

Chapter 10 Forecast and Analysis of the Development of the Automated Pharmacy Industry from 2024 to 2028

Section 1 Forecast and analysis of the future development of China's automated pharmacy industry from 2024 to 2028

1. Analysis of the development direction and investment opportunities of China's automated pharmacy industry

2. Analysis of the development scale of China's automated pharmacy industry from 2024 to 2028

3. Analysis of the development trend of China's automated pharmacy industry from 2024 to 2028

Section 2 Supply and demand forecast of China's automated pharmacy industry from 2024 to 2028

1. Supply forecast of China's automated pharmacy industry from 2024 to 2028

2. Demand forecast for China's automated pharmacy industry from 2024 to 2028

Section 3 Analysis of the price trend of China's automated pharmacy industry from 2024 to 2028

2024-2028 China automated pharmacy industry in-depth research and market investment risk consulting report

Chapter 11 2024-2028 Investment Risk Warning of China's Automated Pharmacy Industry

Section 1 Analysis of Problems in China's Automated Pharmacy Industry

Section 2 Policy Investment Risks of China's Automated Pharmacy Industry

1. Policy and institutional risks

2. Technological development risks

3. Market competition risk

Fourth, the risk of raw material pressure

5. Management risks

Chapter 12 2024-2028 China's automated pharmacy industry development strategy and investment recommendations

Section 1 Analysis of the development strategy of the automated pharmacy industry

1. Adhere to the leading strategy of product innovation

2. Adhere to the guiding strategy of brand building

3. Adhere to the support strategy of technological innovation

Fourth, adhere to the decisive strategy of marketing innovation

Fifth, adhere to the guarantee strategy of enterprise management innovation

Section 2 Implementation of Key Customer Strategy in the Automated Pharmacy Industry Market

First, the necessity of implementing the strategy of key customers

2. Reasonably establish key customers

3. Marketing strategy for key customers

Fourth, strengthen the management of key customers

Fifth, the implementation of the key customer strategy to focus on the problems to be solved

Section 3 Investment Advice

1. Suggestions for key investment areas

2. Suggestions on key investment products

Read on